Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 25 | $3,442,514 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 13 Mar 2025 16:08 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Mar 2025 | Sale | 2,153 | 11.38 | 24,501 | D |
| 07 Mar 2025 16:04 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 05 Mar 2025 | Sale | 1,094 | 11.83 | 12,942 | D |
| 25 Feb 2025 17:09 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 18 Feb 2025 | Sale | 2,598 | 13.95 | 36,242 | D |
| 11 Dec 2024 20:41 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Dec 2024 | Sale | 2,334 | 28.12 | 65,632 | D |
| 18 Nov 2024 16:28 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 18 Nov 2024 | Sale | 2,856 | 28.2 | 80,539 | D |
| 19 Sep 2024 16:51 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 18 Sep 2024 | Sale | 2,339 | 34.55 | 80,812 | D |
| 11 Sep 2024 16:13 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Sep 2024 | Sale | 2,161 | 31.89 | 68,914 | D |
| 20 Aug 2024 16:26 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 19 Aug 2024 | Sale | 296 | 46 | 13,616 | D |
| 20 Aug 2024 16:26 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 19 Aug 2024 | Sale | 2,340 | 45.01 | 105,323 | D |
| 11 Jun 2024 19:42 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Jun 2024 | Sale | 2,136 | 31.34 | 66,942 | D |
| 22 May 2024 21:01 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 20 May 2024 | Sale | 12,147 | 33.51 | 407,046 | D |
| 22 May 2024 21:01 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 20 May 2024 | Sale | 1,145 | 34.08 | 39,022 | D |
| 22 May 2024 21:01 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 20 May 2024 | Sale | 17,134 | 32.49 | 556,684 | D |
| 17 May 2024 21:07 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 16 May 2024 | Sale | 483 | 28.59 | 13,809 | D |
| 17 May 2024 21:07 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 16 May 2024 | Sale | 2,222 | 28.2 | 62,660 | D |
| 12 Mar 2024 21:42 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Mar 2024 | Sale | 2,081 | 25.7 | 53,482 | D |
| 11 Mar 2024 21:56 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 07 Mar 2024 | Sale | 2,373 | 25.85 | 61,342 | D |
| 04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 04 Jan 2024 | Sale | 42,453 | 18.13 | 769,673 | D |
| 04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 03 Jan 2024 | Sale | 5,361 | 20.5 | 109,900 | D |
| 04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 03 Jan 2024 | Sale | 24,583 | 19.05 | 468,306 | D |
| 04 Jan 2024 21:48 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 03 Jan 2024 | Sale | 15,382 | 18.34 | 282,106 | D |
| 12 Dec 2023 17:32 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 11 Dec 2023 | Sale | 1,467 | 10.72 | 15,726 | D |
| 20 Sep 2023 16:47 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 18 Sep 2023 | Sale | 1,436 | 9.41 | 13,513 | D |
| 13 Sep 2023 19:50 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 12 Sep 2023 | Sale | 1,484 | 10.41 | 15,448 | D |
| 14 Jun 2023 18:39 | DYN | Dyne Therapeutics Inc | BESKROVNAYA OXANA | Chief Scientific Officer | 13 Jun 2023 | Sale | 1,475 | 12.43 | 18,334 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)